Viewing Study NCT07290257

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2026-01-28 @ 12:20 PM
Study NCT ID: NCT07290257
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-09-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)
Sponsor: Mirum Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alagille Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALGS View
None Liver Diseases View
None Alagille Syndrome View
None Livmarli View
None Maralixibat View
None Cholestasis View
None Pruritus View
None Itching View
None IBAT inhibitor View